Axcella Health (AXLA) Tops Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Axcella Health (AXLA) Tops Q1 EPS by 2c

Axcella Reports First Quarter Financial Results and Provides Business Update

May 6, 2021 7:28 AM EDT

AXA1665 IND application cleared by FDA for the reduction in risk of recurrent OHE AXA1125 IND application cleared by FDA for the treatment of NASH Initiation of AXA1665 Phase 2 and AXA1125 Phase 2b clinical trials expected shortly Company to host conference call at 8:30 a.m. ET today

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced financial... More